top of page
Executive Team
Under the leadership of of Interim Chief Executive Officer, Mr. Thane Wettig FibroGen’s executive team includes accomplished leaders with deep and broad experience. Supported by a staff of approximately 475 employees worldwide, we are focused on delivering first-in-class medicines for the treatment of unmet medical needs.
Thane Wettig
Interim Chief Executive Officer
Kirk Christoffersen
Chief Business Officer
Christine L. Chung
Senior Vice President,
China Operations
Juan Graham
Chief Financial Officer
John Hunter, Ph.D.
Chief Scientific Officer
Rahul Rajan Kaushik, Ph.D.
Senior Vice President of Pharmaceutical Development, Technical Operations and Manufacturing
Michael D. Lowenstein,
J.D.
Chief Legal Officer
Tricia Stewart
Chief People Officer
bottom of page